Biomarker Open Access is an international, peer-reviewed journal that aims to support those engaged in biomarker research. Journal of Bioequivalence & Bioavailability, Clinical & Experimental Pharmacology, Journal of Cancer Biomarkers, Journal of Circulating Biomarkers, The Open Biomarkers Journal, Journal of Advanced Biomarkers Research, Jacobs Journal of Biomarkers, Journal of Biomarkers in Medicine etc are the related journal associated with this. It provides a rapid communication of the newest advances in the identification of biomarkers, their application towards the discovery of new knowledge and its clinical application. The use of biomarkers in basic and clinical research as well as in clinical practice has become so commonplace that their presence as primary endpoints in clinical trials is now accepted almost without any questionings. This journal offers accelerated publication. Biomarkers have been approved by the U.S Food and Drug Administration (FDA) regulation for use as surrogate endpoints in the treatment development process.